Literature DB >> 31365331

Depression, disability and sleep disturbance are the main explanatory factors of fatigue in rheumatoid arthritis: a path analysis model.

Cristiana F R Silva1, Catia Duarte2, Ricardo J O Ferreira3, Eduardo Santos4, José António Pereira da Silva5.   

Abstract

OBJECTIVES: Fatigue is one of the most prevalent and disabling symptoms among patients with rheumatoid arthritis (RA), however, it is frequently neglected by health professionals. This study aimed to develop a multidimensional explanatory model of fatigue in patients with RA as a basis for better understanding and intervention.
METHODS: This was an ancillary analysis of an observational, cross-sectional, single centre study. Patients completed a questionnaire including demographic data and measures of pain, sleep, disability, anxiety, depression, and personality. Fatigue was assessed by the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F). Disease activity and haemoglobin levels were assessed. Path analysis was performed to test and improve a hypothesised model for fatigue.
RESULTS: This analysis included 142 patients, with a mean (SD) age of 61.1 (11.7) years. The final path analysis model presented acceptable fit and explained 60.0% of the variance of fatigue. The predominant direct explanatory factors identified were disability (46.5%) and depression (41.2%), the latter having an additional indirect influence of 19% through disability. Age (-16.2%) and sleep disturbance (15.7%) were also directly linked to fatigue. Personality trait extroversion (-22.4%), pain (20.0%), and disease activity (14.9%) are only indirectly related to fatigue.
CONCLUSIONS: Depression, disability and sleep disturbance appear to be the main factors explaining fatigue in patients with RA. Disease activity, pain, and personality seem to play only a secondary role, extroversion being the only personality trait associated with fatigue. These findings foster a shift in the paradigm of care towards a more holistic management of fatigue, integrating adjunctive therapies beyond measures targeted solely at disease remission.

Entities:  

Mesh:

Year:  2019        PMID: 31365331

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

1.  Factors affecting quality of life in patients with rheumatoid arthritis in South Korea: a cross-sectional study.

Authors:  Chang-Hee Suh; Kanghyeon Lee; Ji-Won Kim; Sunjoo Boo
Journal:  Clin Rheumatol       Date:  2021-10-05       Impact factor: 2.980

Review 2.  Management of Fatigue in Rheumatoid Arthritis.

Authors:  Janet E Pope
Journal:  RMD Open       Date:  2020-05

3.  Effects of COVID-19 Social Distancing Measures in Individuals with Chronic Pain Living in Spain in the Late Stages of the Lockdown.

Authors:  Jordi Miró; Elisabet Sánchez-Rodríguez; Alexandra Ferreira-Valente; José Pais-Ribeiro; Antonella Ciaramella
Journal:  Int J Environ Res Public Health       Date:  2021-11-09       Impact factor: 3.390

4.  Validity and reliability of the Arabic version of the Self-Efficacy for Managing Chronic Disease scale in rheumatoid arthritis patients.

Authors:  Shymaa A Sarhan; Doaa E Kamal; Mona S Hamed; Dalia I Mostafa
Journal:  Clin Rheumatol       Date:  2022-06-15       Impact factor: 3.650

5.  Anxiety impacts rheumatoid arthritis symptoms and health-related quality of life even at low levels.

Authors:  Dana D DiRenzo; Ethan T Craig; Clifton O Bingham Iii; Susan J Bartlett
Journal:  Clin Exp Rheumatol       Date:  2020-03-05       Impact factor: 4.473

6.  Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis.

Authors:  Hilde Berner Hammer; Brigitte Michelsen; Joe Sexton; Till Uhlig; Sella A Provan
Journal:  Clin Rheumatol       Date:  2020-10-11       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.